Camila Tablet
Product Images NDC 51862-884

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Camila (NDC 51862-884). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Camila 01)

FDA Label Image

Figure 1 (Camila 02)

Figure 1 (Camila 02)
This seems to be a graph or a chart displaying the measured amounts of some substance at different times (in hours). The substance is labeled as "Qral 0.35mg." The quantities of the substance are not provided in the text. Therefore, it is difficult to provide a useful description with this limited information.*
FDA Label Image

Image (Camila 03)

FDA Label Image

Principal Display Panel (0.35 mg Tablet Blister Pack Carton)

Principal Display Panel (0.35 mg Tablet Blister Pack Carton)
Camila® is a brand of oral contraceptive tablets containing 0.35mg of norethindrone USP. Each package includes 3 blister cards with 28 tablets each, and the usual dosage is one tablet daily as directed. Patient instructions are included in each foil pouch and should be provided to the patient by a pharmacist upon dispensing. The tablets should be stored at controlled room temperature, between 20-25°C (68-77°F). Camila® is intended to prevent pregnancy and does not protect against sexually transmitted diseases, including HIV/AIDS. Keep this and all medications out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.